Trial Outcomes & Findings for Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers (NCT NCT01484938)
NCT ID: NCT01484938
Last Updated: 2012-10-10
Results Overview
Percentage corneal staining was assessed by the investigator for each of five regions of the cornea; i.e., four quadrants plus central. The investigator instilled flourescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and yellow filter. Percentage corneal staining was recorded in increments of ten, and the percentages of the five regions were averaged together.
COMPLETED
NA
175 participants
Baseline (Day 0), Day 30
2012-10-10
Participant Flow
Participants were recruited from 3 study centers in the Netherlands, 3 study centers in Sweden, and 1 study center in Australia.
Participant milestones
| Measure |
OPTI-FREE
Multi-purpose contact lens solution used for cleaning, rinsing, disinfecting/storing, and reinserting contact lenses, per protocol-specified regimen.
|
|---|---|
|
Overall Study
STARTED
|
175
|
|
Overall Study
COMPLETED
|
171
|
|
Overall Study
NOT COMPLETED
|
4
|
Reasons for withdrawal
| Measure |
OPTI-FREE
Multi-purpose contact lens solution used for cleaning, rinsing, disinfecting/storing, and reinserting contact lenses, per protocol-specified regimen.
|
|---|---|
|
Overall Study
Adverse Event
|
2
|
|
Overall Study
Lost to Follow-up
|
1
|
|
Overall Study
Noncompliance
|
1
|
Baseline Characteristics
Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers
Baseline characteristics by cohort
| Measure |
OPTI-FREE
n=175 Participants
Multi-purpose contact lens solution used for cleaning, rinsing, disinfecting/storing, and reinserting contact lenses, per protocol-specified regimen.
|
|---|---|
|
Age Continuous
|
37.6 years
STANDARD_DEVIATION 11.66 • n=5 Participants
|
|
Sex: Female, Male
Female
|
111 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
64 Participants
n=5 Participants
|
|
Region of Enrollment
Netherlands
|
72 participants
n=5 Participants
|
|
Region of Enrollment
Sweden
|
75 participants
n=5 Participants
|
|
Region of Enrollment
Australia
|
28 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline (Day 0), Day 30Population: Intent to treat. All subjects who were enrolled in the study and completed at least one on-regimen study visit were evaluable for intent-to-treat analyses.
Percentage corneal staining was assessed by the investigator for each of five regions of the cornea; i.e., four quadrants plus central. The investigator instilled flourescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and yellow filter. Percentage corneal staining was recorded in increments of ten, and the percentages of the five regions were averaged together.
Outcome measures
| Measure |
OPTI-FREE
n=171 Participants
Multi-purpose contact lens solution used for cleaning, rinsing, disinfecting/storing, and reinserting contact lenses, per protocol-specified regimen.
|
|---|---|
|
Mean Change From Baseline (Day 0) in Average Corneal Staining Area at Day 30
|
-5.04 Percentage of corneal staining
Standard Deviation 16.119
|
PRIMARY outcome
Timeframe: Baseline (Day 0), Day 30Population: Intent to treat. All subjects who were enrolled in the study and completed at least one on-regimen study visit were evaluable for intent-to-treat analyses.
Corneal staining type was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central. The investigator instilled flourescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and yellow filter. Corneal staining type was recorded on a 5-point scale for each region: 0=none; 1=micropunctate; 2=macropunctate; 3=coalesced macropunctate; 4=patch (\>/= 1 mm). The five regions were summed, for a summed total range of 0-20.
Outcome measures
| Measure |
OPTI-FREE
n=171 Participants
Multi-purpose contact lens solution used for cleaning, rinsing, disinfecting/storing, and reinserting contact lenses, per protocol-specified regimen.
|
|---|---|
|
Mean Change From Baseline (Day 0) in Total Corneal Staining Type at Day 30
|
-0.82 Units on a scale
Standard Deviation 1.777
|
Adverse Events
OPTI-FREE
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Jami Kern, Ph.D., Global Medical Affairs
Alcon Research, Ltd.
Results disclosure agreements
- Principal investigator is a sponsor employee Alcon reserves the right of prior review of any publication or presentation of information related to the study.
- Publication restrictions are in place
Restriction type: OTHER